InsidersTradesSigma
Discover the full record of transactions filed by Carter Jennifer M., Directrice. Director active across 2 companies, notably Augmedix, Inc.. Aggregated, 2 filings have been recorded. Total volume traded: €599k. The latest transaction was disclosed on 28 October 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Jennifer M. Carter is a Director at Augmedix, Inc. She contributes to the strategy and governance of the company, bringing her expertise in the technology sector. Her role is essential in guiding strategic decisions and ensuring the smooth operation of the organization.